Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Daiichi, ArQule cancer drug fails in late-stage study
Daiichi, ArQule cancer drug fails in late-stage study
Daiichi, ArQule cancer drug fails in late-stage study
Submitted by
admin
on February 18, 2017 - 2:43pm
Source:
BioPharma Dive
News Tags:
Daiichi Sankyo
Arqule
clinical trials
tivantinib
liver cancer
Headline:
Daiichi, ArQule cancer drug fails in late-stage study
Do Not Allow Advertisers to Use My Personal information